Product Information
CEFEPIME HCL 1 GM VIAL is a generic product labeled by WG Critical Care, LLC, priced at $3.7308 per EA under NDC 44567013010. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
1 g/20mL
Manufacturer
WG Critical Care, LLCNDC
44567013010
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
8/20/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441On Market Since
3/31/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 1 GM VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7308 per EA |
|---|---|
| All-time high | $3.9442 (Nov 13, 2024) |
| All-time low | $3.3241 (Apr 23, 2025) |
| 52-week high | $3.7308 |
| 52-week low | $3.5001 |
| Median price | $3.7308 |
| Average price | $3.6430 |
| Largest weekly change | -10.4% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 1 GM VIAL, manufactured by WG Critical Care, LLC, is $3.7308 per EA (NDC 44567013010), effective Jun 24, 2026.
How has the price of CEFEPIME HCL 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 1 GM VIAL has risen 3.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 1 GM VIAL?
Since Apr 17, 2024, the NADAC for CEFEPIME HCL 1 GM VIAL has ranged from a low of $3.3241 (Apr 23, 2025) to a high of $3.9442 (Nov 13, 2024), with a median of $3.7308 per EA.
Are there cheaper alternatives to CEFEPIME HCL 1 GM VIAL?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CEFEPIME HCL 1 GM VIAL, but none are currently priced below it.
Who manufactures CEFEPIME HCL 1 GM VIAL?
CEFEPIME HCL 1 GM VIAL (NDC 44567013010) is labeled by WG Critical Care, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification